Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Murphy, L. C.
Right arrow Articles by Haddad-Alkhalaf, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Murphy, L. C.
Right arrow Articles by Haddad-Alkhalaf, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 9, No. suppl_1, pp. 174-180, 1994
© 1994 European Society of Human Reproduction and Embryology

Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins

Leigh C. Murphy, Moussa Alkhalaf, Helmut Dotzlaw, Amanda Coutts and Bouran Haddad-Alkhalaf

Department of Biochemistry and Molecular Biology, University of Manitoba Winnipeg R3E 0W3, Canada

The molecular mechanisms by which progestins and antiprogestins inhibit human breast cancer cell growth are essentially unknown. The mechanisms by which they mediate growth inhibition in human breast cancer cells and the expression of the putative autocrine/paracrine growth factors, epidermal growth factor and transforming growth factors {alpha} and β-1 were studied under conditions in which progestin and antiprogestin inhibit the growth of T-47D human breast cancer cells in culture. Under the same conditions, the expression of genes such as c-myc, c-jun and c-fos, which are known to have important roles in growth and differentiation, has been measured. The results indicate that progestins and antiprogestins differentially regulate expression of these genes. The data are consistent with the conclusion that the mechanism of growth inhibition of these two agents differs, although an initial interaction with the progesterone receptor is a necessary first step in initiating the as yet ill-defined cascade of events leading to growth inhibition.

Key words: antiprogestin/breast cancer/gene expression/progestin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Reproductive SciencesHome page
C. C. Schneider, R. K. Gibb, D. D. Taylor, T. Wan, and C. Gercel-Taylor
Inhibition of Endometrial Cancer Cell Lines by Mifepristone (RU 486)
Reproductive Sciences, November 1, 1998; 5(6): 334 - 338.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.